| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |